Description
A taurine-conjugated form of CDCA; serum levels increase approximately 5-fold in within two hours and begin to decrease within four hours during an oral lipid tolerance test in humans; serum levels are increased in patients with liver cirrhosis and may serve as a marker of disease progression
Formal name: 2-[[(3α,5β,7α)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-ethanesulfonic acid, monosodium salt
Synonyms: NSC 681055|Taurochenodeoxycholate|TCDCA
Molecular weight: 521.7
CAS: 6009-98-9
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Research Area|Endocrinology & Metabolism|Bile Acids & Microbiome